MSH2 and hepatocellular carcinoma: Promoter methylation of MLH1, PMS2, MSH2 and p16 was analysed by MSP in tumour and non-tumour adjacent tissue of 61 patients with HCC of which 34 were associated with HCV, 10 with HBV and 17 with alcoholic liver disease (Table 1).